Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Robert J. Heddle"'
Autor:
Robert J. Heddle, Yoshikazu Honda-Okubo, Hayley E. Rose, Simon G A Brown, Noel W. Davies, Nikolai Petrovsky, Richard J. Woodman, Michael D. Wiese, Troy Wanandy
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Highlights • Current allergen immunotherapy approaches are limited by long treatment duration, cost and adverse reactions. • Immune adjuvants may improve efficacy, durability and cost of allergen immunotherapy. • Delta inulin (Advax™) is a we
Autor:
David B.K. Golden, Julij Šelb, Thilo Jakob, Fares Zaitoun, Harfi Harb, Bernard Yu-Hor Thong, Michael Levin, Peter Korošec, Robert J. Heddle, S. Karabus, Ricardo de Lima Zollner
Publikováno v:
The World Allergy Organization journal, vol. 12, no. 10, pp. 1-11, 2019.
World Allergy Organization Journal, Vol 12, Iss 10, Pp-(2019)
The World Allergy Organization Journal
World Allergy Organization Journal, Vol 12, Iss 10, Pp-(2019)
The World Allergy Organization Journal
Venom immunotherapy is the standard of care for people with severe reactions and has been proven to reduce risk of future anaphylactic events. There is a moral imperative to ensure production, supply and worldwide availability of locally relevant, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a44f8b5218158a24aa428231e4553fd
https://hdl.handle.net/20.500.12556/DiRROS-12435
https://hdl.handle.net/20.500.12556/DiRROS-12435
Autor:
Anthony J.F. Smith, Pravin Hissaria, Aida Ahmadie, William B Smith, Robert J. Heddle, Frank Kette, Jie Shen Fok
Publikováno v:
Internal Medicine Journal. 49:1552-1553
Autor:
Robert J. Heddle, Thanh-Thao Adriana Le, J.-A. Tan, Anthony J.F. Smith, M. Al Kindi, Frank Kette, William B Smith, Pravin Hissaria
Publikováno v:
Internal Medicine Journal. 46:710-716
Background IgE-mediated allergy to the wheat protein omega-5-gliadin (O5G) is associated with wheat-dependent exercise-induced anaphylaxis (WDEIA), where exercise acts as a cofactor, triggering anaphylaxis after wheat ingestion. The wider application
Autor:
Carlo Yuson, Kimti Kumar, Pravin Hissaria, William B Smith, Frank Kette, Tatjana Banovic, A Le, Aida Ahmadie, Robert J. Heddle
Publikováno v:
Internal medicine journal. 49(8)
Background Patients who suffer from acute IgE-mediated allergy to a cephalosporin antibiotic are frequently assumed to be at high risk of allergy to other cephalosporins and penicillins. Aim To define cross-reactivity patterns in patients with confir
Publikováno v:
The Journal of Allergy and Clinical Immunology
Background Allergic reactions to Hymenoptera insect stings remain a major global clinical problem. Although effective, parenteral desensitization regimens require use of costly venom extracts and require frequent visits over extended periods of time.
Publikováno v:
British Journal of Clinical Pharmacology. 78:1-13
Hypersensitivity reactions including anaphylaxis have been reported for nearly all classes of therapeutic reagents and these reactions can occur within minutes to hours of exposure. These reactions are unpredictable, not directly related to dose or t
Autor:
Debra J. Palmer, Susan L. Prescott, Thomas Sullivan, Maria Makrides, Robert J. Heddle, Michael Gold, Robert A. Gibson
Publikováno v:
Allergy. 68:1370-1376
Background Diets high in n-3 long chain polyunsaturated fatty acids (LCPUFA) may modulate the development of IgE-mediated allergic disease and have been proposed as a possible allergy prevention strategy. The aim of this study was to determine whethe
Autor:
Robert J. Heddle, Frank Kette, Tauseef Chaudhry, William B Smith, Pravin Hissaria, Michael D. Wiese
Publikováno v:
Internal Medicine Journal. 42:665-671
Background: Urticaria, angioedema and anaphylaxis are common adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs). Aim: To investigate the clinical characteristics of NSAID-induced acute hypersensitivity reactions with structured oral
Autor:
Karl Bleasel, Robert G Stirling, Darryl W. Maher, Robert J. Heddle, Carolyn Stone, Pravin Hissaria
Publikováno v:
Internal Medicine Journal. 42:252-259
Background and aims: Intragam® 10 NF is the next generation 10% intravenous immunoglobulin with three pathogen reduction steps and a noncarbohydrate stabiliser. This open label, cross-over study in patients with primary immunodeficiency was designed